IFF

International Flavors & Fragrances Inc. NYSE

Basic Materials ·Chemicals - Specialty ·US · iff.com

$70.81

After hrs $70.09 +0.01%

Mkt Cap $18.1B

52w Low $59.14 46.1% of range 52w High $84.45

50d MA $73.45 200d MA $68.87

P/E (TTM) -48.5x

EV/EBITDA 29.9x

P/B 1.3x

Debt/Equity 0.5x

ROE 2.0%

P/FCF 67.4x

RSI (14) —

ATR (14) —

Beta 1.03

50d MA $73.45

200d MA $68.87

Avg Volume 1.7M

About

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-ba…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 11, 2026	AMC	0.83	0.80	-3.4%	76.97	+2.5%	+5.9%	+7.8%	+7.5%	+7.8%	+6.0%	-9.6%	—
Nov 4, 2025	AMC	1.02	1.05	+2.9%	61.49	+2.0%	+4.1%	+2.2%	+0.8%	+2.1%	+6.2%	+8.1%	—
Aug 5, 2025	AMC	1.12	1.15	+2.7%	70.62	+4.7%	-6.3%	-9.0%	-10.0%	-10.1%	-8.6%	-7.2%	—
May 6, 2025	AMC	1.13	1.20	+6.2%	79.20	-2.0%	-7.1%	-6.5%	-7.3%	-3.6%	-3.4%	-3.5%	—
Feb 18, 2025	AMC	0.83	0.97	+16.9%	86.45	-6.3%	-5.2%	-7.3%	-7.6%	-7.9%	-7.1%	-7.8%	—
Nov 5, 2024	AMC	1.07	1.04	-2.8%	99.10	-4.1%	-11.6%	-8.2%	-6.9%	-8.0%	-9.8%	-10.2%	—
Aug 6, 2024	AMC	0.99	1.16	+16.7%	96.48	+2.8%	-2.4%	-1.0%	-0.3%	-0.7%	+0.1%	+6.4%	—
May 6, 2024	AMC	0.86	1.13	+31.7%	88.66	+4.4%	+6.4%	+9.7%	+9.5%	+9.6%	+8.9%	+10.6%	—
Feb 20, 2024	AMC	0.75	0.72	-4.0%	82.03	-9.2%	-6.4%	-3.1%	-1.9%	-5.6%	-9.3%	+1.6%	—
Nov 6, 2023	AMC	0.76	0.89	+17.1%	72.34	+7.8%	-1.0%	-1.8%	-1.1%	-0.8%	-1.5%	+4.7%	—
Aug 7, 2023	AMC	1.10	0.86	-21.8%	80.34	-22.0%	-19.4%	-20.6%	-21.3%	-20.0%	-19.1%	-11.6%	—
May 8, 2023	AMC	0.89	0.87	-2.2%	97.14	-3.9%	-7.0%	-10.7%	-12.1%	-14.4%	-13.2%	-16.4%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 22	Oppenheimer	Maintains	Outperform → Outperform	—	$72.42	$72.94	+0.7%	-1.7%	-2.0%	-1.8%	-2.0%	-2.3%
Apr 14	Barclays	Maintains	Overweight → Overweight	—	$71.70	$71.50	-0.3%	+1.2%	-0.2%	+0.5%	+5.8%	+3.8%
Apr 13	Citigroup	Maintains	Buy → Buy	—	$72.52	$71.97	-0.8%	-1.1%	+0.1%	-1.4%	-0.6%	+4.6%
Apr 9	UBS	Maintains	Neutral → Neutral	—	$73.77	$72.82	-1.3%	-0.9%	-1.7%	-2.8%	-1.6%	-3.0%
Feb 17	Mizuho	Maintains	Outperform → Outperform	—	$83.00	$84.00	+1.2%	-0.3%	-0.0%	-1.7%	-1.9%	-0.9%
Feb 17	Barclays	Maintains	Overweight → Overweight	—	$83.00	$84.00	+1.2%	-0.3%	-0.0%	-1.7%	-1.9%	-0.9%
Feb 13	Wells Fargo	Maintains	Overweight → Overweight	—	$81.50	$82.50	+1.2%	+1.8%	+1.5%	+1.8%	+0.1%	-0.1%
Feb 13	Citigroup	Maintains	Buy → Buy	—	$81.50	$82.50	+1.2%	+1.8%	+1.5%	+1.8%	+0.1%	-0.1%
Feb 13	Oppenheimer	Upgrade	Perform → Outperform	—	$81.50	$82.50	+1.2%	+1.8%	+1.5%	+1.8%	+0.1%	-0.1%
Feb 12	Mizuho	Maintains	Outperform → Outperform	—	$76.97	$78.88	+2.5%	+5.9%	+7.8%	+7.5%	+7.8%	+6.0%
Jan 22	Argus	Maintains	Buy → Buy	—	$71.30	$71.51	+0.3%	+1.2%	+2.7%	+3.8%	+2.7%	+1.2%
Jan 21	Citigroup	Maintains	Buy → Buy	—	$70.86	$71.50	+0.9%	+0.6%	+1.8%	+3.3%	+4.5%	+3.3%
Jan 12	UBS	Maintains	Neutral → Neutral	—	$69.10	$69.42	+0.5%	-0.2%	+0.7%	+1.6%	+2.5%	+3.7%
Nov 7	Barclays	Maintains	Overweight → Overweight	—	$62.85	$63.16	+0.5%	-1.4%	-0.1%	+3.9%	+4.1%	+7.3%
Nov 6	UBS	Maintains	Neutral → Neutral	—	$64.00	$64.32	+0.5%	-1.8%	-3.1%	-1.9%	+2.0%	+2.2%
Oct 14	BofA Securities	Maintains	Buy → Buy	—	$60.10	$60.00	-0.2%	+2.6%	+3.0%	+4.2%	+6.1%	+7.6%
Oct 7	Argus	Maintains	Buy → Buy	—	$61.50	$61.85	+0.6%	-0.8%	-0.3%	-2.2%	-3.2%	-2.3%
Oct 6	UBS	Maintains	Neutral → Neutral	—	$62.18	$62.05	-0.2%	-1.1%	-1.9%	-1.4%	-3.3%	-4.2%
Oct 6	Citigroup	Maintains	Buy → Buy	—	$62.18	$62.05	-0.2%	-1.1%	-1.9%	-1.4%	-3.3%	-4.2%
Oct 3	Mizuho	Maintains	Outperform → Outperform	—	$61.51	$61.35	-0.3%	+1.1%	-0.0%	-0.8%	-0.3%	-2.2%
Sep 22	Morgan Stanley	Maintains	Overweight → Overweight	—	$63.53	$63.33	-0.3%	-2.1%	-1.8%	-1.6%	-5.1%	-4.4%
Sep 8	Wolfe Research	Upgrade	Underperform → Peer Perform	—	$66.03	$67.03	+1.5%	+0.2%	-1.5%	-2.3%	+0.5%	-0.6%
Aug 26	Tigress Financial	Maintains	Buy → Buy	—	$67.14	$67.11	-0.0%	-0.6%	-0.5%	-0.1%	+0.6%	-0.9%
Aug 8	Barclays	Maintains	Overweight → Overweight	—	$64.23	$64.50	+0.4%	-1.0%	-1.2%	+0.5%	+3.5%	+2.3%
Aug 7	Wells Fargo	Maintains	Overweight → Overweight	—	$66.16	$65.79	-0.6%	-2.9%	-3.9%	-4.1%	-2.4%	+0.5%
Aug 6	UBS	Maintains	Neutral → Neutral	—	$70.62	$73.94	+4.7%	-6.3%	-9.0%	-10.0%	-10.1%	-8.6%
May 13	Morgan Stanley	Maintains	Overweight → Overweight	—	$76.35	$76.50	+0.2%	+0.2%	-2.3%	-0.3%	+1.8%	+1.3%
May 8	Citigroup	Maintains	Buy → Buy	—	$73.59	$74.70	+1.5%	+0.7%	-0.2%	+3.8%	+4.0%	+1.4%
May 8	Barclays	Upgrade	Equal Weight → Overweight	—	$73.59	$74.70	+1.5%	+0.7%	-0.2%	+3.8%	+4.0%	+1.4%
May 8	Baird	Maintains	Outperform → Outperform	—	$73.59	$74.70	+1.5%	+0.7%	-0.2%	+3.8%	+4.0%	+1.4%
May 7	UBS	Maintains	Neutral → Neutral	—	$79.20	$77.59	-2.0%	-7.1%	-6.5%	-7.3%	-3.6%	-3.4%
Apr 22	Oppenheimer	Maintains	Outperform → Outperform	—	$72.71	$73.51	+1.1%	+2.7%	+4.3%	+5.4%	+4.9%	+4.9%
Apr 15	Mizuho	Maintains	Outperform → Outperform	—	$73.48	$73.14	-0.5%	-1.3%	-3.3%	-1.3%	-1.0%	+1.6%
Apr 14	Barclays	Maintains	Equal Weight → Equal Weight	—	$73.17	$73.77	+0.8%	+0.4%	-0.9%	-2.9%	-0.9%	-0.6%
Apr 10	Stifel	Maintains	Buy → Buy	—	$72.97	$72.28	-0.9%	-2.2%	+0.3%	+0.7%	-0.7%	-2.6%
Apr 10	Morgan Stanley	Maintains	Overweight → Overweight	—	$72.97	$72.28	-0.9%	-2.2%	+0.3%	+0.7%	-0.7%	-2.6%
Apr 9	Wells Fargo	Maintains	Overweight → Overweight	—	$66.85	$66.31	-0.8%	+9.2%	+6.8%	+9.5%	+9.9%	+8.4%
Apr 8	Citigroup	Maintains	Buy → Buy	—	$70.71	$71.69	+1.4%	-5.5%	+3.2%	+0.9%	+3.5%	+3.9%
Mar 27	Barclays	Maintains	Equal Weight → Equal Weight	—	$77.66	$77.69	+0.0%	+0.7%	-1.5%	-0.1%	-0.3%	+1.2%
Feb 20	Oppenheimer	Maintains	Outperform → Outperform	—	$81.99	$81.56	-0.5%	-2.3%	-2.6%	-2.9%	-2.1%	-1.7%
Feb 20	BofA Securities	Maintains	Buy → Buy	—	$81.99	$81.56	-0.5%	-2.3%	-2.6%	-2.9%	-2.1%	-1.7%
Feb 20	JP Morgan	Maintains	Overweight → Overweight	—	$81.99	$81.56	-0.5%	-2.3%	-2.6%	-2.9%	-2.1%	-1.7%
Feb 20	Wells Fargo	Maintains	Overweight → Overweight	—	$81.99	$81.56	-0.5%	-2.3%	-2.6%	-2.9%	-2.1%	-1.7%
Feb 3	Stifel	Maintains	Buy → Buy	—	$87.09	$85.38	-2.0%	-0.8%	-1.7%	-1.0%	-1.6%	-3.2%
Jan 28	Oppenheimer	Maintains	Outperform → Outperform	—	$87.63	$87.36	-0.3%	-1.2%	-1.9%	+0.1%	-0.6%	-1.4%
Jan 17	Barclays	Maintains	Equal Weight → Equal Weight	—	$84.44	$84.81	+0.4%	+0.5%	+1.3%	+1.2%	+2.4%	+1.7%
Jan 7	Argus	Upgrade	Hold → Buy	—	$82.11	$83.11	+1.2%	+0.5%	-0.0%	-0.9%	+1.4%	+1.9%
Dec 18	Citigroup	Maintains	Buy → Buy	—	$86.77	$86.30	-0.5%	-1.6%	-1.0%	-1.2%	-2.3%	-1.9%
Nov 12	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$91.21	$91.64	+0.5%	-2.0%	-1.5%	-2.0%	-5.6%	-5.0%
Nov 7	Vertical Research	Upgrade	Hold → Buy	—	$87.57	$88.15	+0.7%	+3.9%	+5.4%	+4.2%	+2.1%	+2.6%

Recent Filings

8-K

International Flavors & Fragrances Inc. -- 8-K Filing

International Flavors & Fragrances reported Q4 and full-year 2025 earnings results, providing investors with updated financial performance metrics and guidance for assessing the company's operational trajectory.

Feb 11

Data updated apr 25, 2026 3:04pm · Source: massive.com